These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11000065)

  • 1. Male predominance in hepatocellular carcinoma: new insight and a possible therapeutic alternative.
    Lui WY; Lin HL; Chau GY; Liu TY; Chi CW
    Med Hypotheses; 2000 Oct; 55(4):348-50. PubMed ID: 11000065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormones and risk of liver tumor.
    Giannitrapani L; Soresi M; La Spada E; Cervello M; D'Alessandro N; Montalto G
    Ann N Y Acad Sci; 2006 Nov; 1089():228-36. PubMed ID: 17261770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma.
    Lau WY; Leow CK; Li AK
    Br J Hosp Med; 1997 Feb 5-18; 57(3):101-4. PubMed ID: 9196588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary treatment of patients with hepatocellular carcinoma.
    Masaki T; Morishita A; Kurokohchi K; Kuriyama S
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1377-84. PubMed ID: 17069523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
    Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma.
    Naugler WE; Schwartz JM
    Dis Mon; 2008 Jul; 54(7):432-44. PubMed ID: 18570913
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatocellular carcinoma: increasing incidence and optimized management].
    Trinchet JC
    Gastroenterol Clin Biol; 2009; 33(8-9):830-9. PubMed ID: 19541440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence.
    Moore SW; Millar AJ; Hadley GP; Ionescu G; Kruger M; Poole J; Stones D; Wainwright L; Chitnis M; Wessels G
    Cancer; 2004 Aug; 101(3):642-9. PubMed ID: 15274079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: role of estrogen receptors in the liver.
    Villa E; Grottola A; Colantoni A; De Maria N; Buttafoco P; Ferretti I; Manenti F
    Ann N Y Acad Sci; 2002 Jun; 963():37-45. PubMed ID: 12095926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma.
    Marrero JA
    Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: latest developments.
    Walzer N; Kulik LM
    Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
    Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
    Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats.
    Dombrowski F; Flaschka C; Klotz L; von Netzer B; Schulz C; Lehnert H; Evert M
    Hepatology; 2006 Apr; 43(4):857-67. PubMed ID: 16557532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.